Replies to post #47346 on OncoSec Medical Inc (ONCSQ)

[jckrdu]

We'll see how it shakes out. IMO, with this CGP deal, ONCS is telling the market that they're open to discussing any buyout offers at a $4.50 floor.

It may bring others to the table as - pending shareholder approval - CGP is about to own 53% of ONCS for a measly $30M. Seems like if Merck had any interest at all in ONCS technology/KeyNote studies, this pending deal would bring them to the table with a competing offer. Heck, they could double or triple CGPs offer and it'd still be less than peanuts for Merck. We'll find out soon enough.